Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CTNNB1 |
Variant | D32_I35delinsV |
Impact List | indel |
Protein Effect | unknown |
Gene Variant Descriptions | CTNNB1 D32_I35delinsV results in a deletion of four amino acids within the ubiquitination recognition motif of the Ctnnb1 protein from amino acids 32 to 35, combined with the insertion of a valine (V) at the same site (PMID: 15064718). D32_I35delinsV has not been characterized in the scientific literature and therefore, its effect on Ctnnb1 protein function is unknown (PubMed, Jul 2024). |
Associated Drug Resistance | |
Category Variants Paths |
CTNNB1 mutant CTNNB1 D32_I35delinsV |
Transcript | NM_001098210.2 |
gDNA | chr3:g.41224607_41224615delACTCTGGAA |
cDNA | c.95_103delACTCTGGAA |
Protein | p.D32_I35delinsV |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001904.3 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_017005738.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_047447478.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_017005738.2 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
NM_001098210.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_024453357.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_006712985.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_047447479.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_047447483.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
NM_001904.4 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_024453356.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_006712985.2 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_047447480.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
NM_001098209.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_047447477.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
NM_001098209.2 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
NM_001098210.2 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_024453356.2 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_047447481.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
XM_024453358.1 | chr3:g.41224607_41224615delACTCTGGAA | c.95_103delACTCTGGAA | p.D32_I35delinsV | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|